2027 ICD-10-CM Diagnosis Code D69.3Immune thrombocytopenic purpura
ICD-10-CM Codes›D50–D89›D65-D69›D69
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Risk Adjusts — HCC 112
- Chronic Condition
D69.3 is a billable ICD-10-CM diagnosis code for immune thrombocytopenic purpura. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 813. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 53 closely related codes. Coders also document this condition as chronic hemolytic anemia. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.
For Medicare Advantage risk adjustment, D69.3 maps to CMS-HCC Category 112 (Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions) under the V28 model, adding a risk factor of about 0.450 for a community, non-dual, aged beneficiary in payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
D69.3 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Chronic hemolytic anemia
- Chronic idiopathic thrombocytopenic purpura
- Cyclic thrombocytopenia
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to D69.3: its own notes plus those printed at D69 and Chapter 3. A note printed at a category, block or chapter applies to every code under it.
Applicable To
Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.
- Hemorrhagic (thrombocytopenic) purpura
- Idiopathic thrombocytopenic purpura
- Tidal platelet dysgenesis
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name D69.3, its category, or a range that includes it.
Excludes1 2
These codes carry an Excludes1 note naming D69.3: they are not reported together with it, unless the two conditions are unrelated.
Excludes2 1
These codes carry an Excludes2 note naming D69.3: its condition is not part of those codes, and both may be reported when the patient has both.
- Block R70-R79 Abnormal findings on examination of blood, without diagnosisabnormalities of platelets and thrombocytes (D69.-) names D69.-, which includes this code
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
tidal platelet D69.3
immune thrombocytopenic D69.3
hemorrhagic D69.3
idiopathic D69.3
immune D69.3
Thrombocytopenia, thrombocytopenic D69.6
essential D69.3
idiopathic D69.3
idiopathic D69.3
Werlhof's disease D69.3
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Purpura, Thrombocytopenic, Idiopathic
thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. it is mediated by immune mechanisms, in most cases immunoglobulin g autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. the disease is seen in acute (affecting children) and chronic (adult) forms.
Patient EducationClinical
Platelet Disorders
Platelets, also known as thrombocytes, are blood cells. They form in your bone marrow, a sponge-like tissue in your bones. Platelets play a major role in blood clotting. Normally, when one of your blood vessels is injured, you start to bleed.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D69.3 to ICD-9-CMHistory
Code HistoryHistory
Questions About D69.3Overview
What is the ICD-10 code for immune thrombocytopenic purpura?
The ICD-10-CM code for immune thrombocytopenic purpura is D69.3 (sometimes written as D693). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is D69.3 (Purpura and other hemorrhagic conditions) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report immune thrombocytopenic purpura on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does D69.3 group to?
When immune thrombocytopenic purpura is the principal diagnosis on an inpatient stay, it groups to MS-DRG 813 (coagulation Disorders), which carries a relative weight of 1.5279. Higher weights mean higher Medicare reimbursement.
Is D69.3 a CC or MCC?
CMS lists D69.3 as a CC (complication or comorbidity) for FY 2027. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 53 closely related codes in its exclusion list.
Can D69.3 be reported with D89.0?
Not as a rule. The Excludes1 note at D69, which applies to D69.3, lists "benign hypergammaglobulinemic purpura (D89.0)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
What HCC is D69.3?
D69.3 (immune thrombocytopenic purpura) maps to CMS-HCC Category 112 (Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions), commonly written as HCC 112, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 48 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 100.
Does D69.3 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, D69.3 adds a risk adjustment factor of about 0.450 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.450 to 0.708 depending on the payment segment). A more severe related category (HCC 111) supersedes it when both are reported. See the full factor table on the HCC 112 category page.
